Influenza: Diagnosis, Treatment, Prevention - V.D. Moskalyuk 2010

References

1. Azymov, A.G. On The Role of immunoglobulin E in pathology // Allergology. - 2002. - № 2. - P. 73-76.

2. Aksenov, O.V., Platonova, G.A., & Timkovsky, A.L. Broadening the action Specificity of polynucleotide interferon Inducers // Antibiotics and Chemotherapy. - 1999. - Vol. 44, № 9. - P. 10-12.

3. Alekseev, K.V., & Shaldyrvan, E.A. Dosage forms of interferon // Antibiotics and Chemotherapy. - 1990. - Vol. 35, № 9. - P. 51-54.

4. Aleksina, S.G., Dorokhova, N.F., Izvolskaya, Z.A., et al. Experience with the Vaxigrip vaccine in pediatric and adult populations // Vaccination. - 1999. - № 5. - P. 10-11.

5. Amosova, E.N., & Burchinsky, S.G. Clinical and pharmacological aspects of the efficacy of Coldrex group drugs in the Treatment of colds in general practice // Journal of the Practical Physician. - 2000. - № 3. - P. 50-53.

6. Andreichyn, M.A. Acute respiratory infections (lectures). - Ternopil: Ukrmedknyha, 1999. - 38 p.

7. Andronati, S.A., Litvinova, L.A., & Golovenko, N.Y. Amixin, an oral inducer of endogenous interferon, and its analogues // Journal of the AMS of Ukraine. - 1999. - Vol. 5, № 1. - P. 53-66.

8. Aronova, M.M. Operational monitoring of the Influenza and ARI epidemic process in Ukraine during the 2001-2002 epidemic season // Modern Infections. - 2002. - № 2. - P. 8-10.

9. Bakova, A.A., Brondz, B.D., Fedorkina, O.A., et al. The Use of Monoclonal Antibodies for influenza virus detection // Problems of Virology. - 1994. - № 4. - P. 187-189.

10. Belov, A.B. Avian influenza and atypical Pneumonia (clinical and epidemiological parallels) // Infectious Diseases: Proc. Sci.-Pract. Conf. on Public Health and Military Medicine Problems (March 22-24, 2006). - St. Petersburg, 2006. - P. 44.

11. Belyaev, A.L., Burtseva, E.I., Slepushkin, A.N., et al. Arbidol: a new agent for the Prevention of influenza and acute respiratory viral infections in children // Bulletin of the RAMS. - 1996. - № 8. - P. 34-37.

12. Berezhnoy, V.V., Ershova, I.B., & Kunegina, E.N. Acute respiratory viral infections in children and adolescents. - Kyiv-Luhansk, 2003. - 117 p.

13. Bobylova O.O., Berezhnov S.P., Mukharska L.M. et al. Structure/149.html">The problem of infectious morbidity remains a pressing issue for the healthcare system and the state // Suchasni Infektsiyi. - 2001. - № 1. - P. 4-10.

14. Bobylova O.O., Berezhnov S.P., Mukharska L.M. et al. Epidemic and sanitary-hygienic situation in Ukraine // Suchasni Infektsiyi. - 2002. - № 2. - P. 4-7.

15. Bogomolov B.P. Diagnostics, Clinical Features, treatment, and prevention of influenza and other acute respiratory diseases // Klin. Med. - 1990. - № 8. - P. 115-121.

16. Bogomolov B.P., Devyatkin A.V., Molkova T.N. Clinical evaluation of hemorheological disorders in complications of influenza and acute respiratory viral infections // Klin. Med. - 1996. - № 2. - P. 10­12.

17. Bogomolov B.P., Molkova T.N., Devyatkin A.V. On Cardiovascular system Changes in patients with respiratory syncytial infection // Klin. Med. - 2001. - № 6. - P. 28-30.

18. Bogomolov B.P. Cytology/practical/136.html">Differential Diagnosis OF infectious diseases. - M., 2000. - P. 92-106.

19. Bogomolov B.P., Devyatkin A.V., Mityushina S.A. Experience in correcting Homeostasis disorders in influenza and other acute respiratory viral infections in hypertensive patients // Infectious Diseases: Public Health and Military Medicine Problems: Russian Scientific-Practical Conference (22-24.03.2006). - St. Petersburg, 2006. - P. 50-51.

20. Boreko E.N., Pavlova N.P., Zaitseva G.V., Mikhailopulo I.A. Antiviral activity of 2-deoxy-2-fluoroguanosine against influenza and herpes simplex Viruses in Cell cultures // Vopr. Virusol. - 2001. - № 5. - P. 40-42.

21. Burchynsky S.G. The multipotency of pharmacological effect as The basis of modern Pathogenetic Therapy for common colds // Farmakol. Visnyk. - 1998. - № 1. - P. 36-37.

22. Burtseva E.I., Slepushkin A.N., Belyaeva A.L. et al. "Grippol" as an effective vaccine for the immunization of elderly individuals against influenza // Immunologiya. - 2000. - Vol. 25, № 2. - P. 39-42.

23. Vasylenko Yu.S. Inhalation nebulizer therapy for Upper Respiratory Tract and vocal apparatus diseases using the "Boreal" inhaler. Guidelines for physicians. - 2001. - "Inter-Eton LLC". - 22 p.

24. Venhlovska Ya.V., Bohachyk N.A., Trefanenko A.H., Nosova H.A. Therapeutic efficacy of amizon in acute respiratory viral infections in adults // Neuroinfections. Other Infectious Diseases: Proceedings of the Scientific-Practical Conference and Plenum of the Association of Infectiologists of Ukraine (April 26-27, 2001, Kharkiv). - Ternopil: Ukrmedknyha, 2001. - P. 191-192.

25. Vershinina M.Yu., Narovlyansky A.N., Deryabin P.G. et al. Regulation of cytokine mRNA activity by interferon and its inducers // Rus. J. Immunol. - 2002. - № 2. - P. 161-166.

26. Vishnyakova L.A., Putov N.V. Etiology of acute pneumonia // Therapeutic Archive. - 1990. - № 3. - P. 15-18.

27. Vozianova Zh.I. Influenza // Infectious and Parasitic Diseases: In 3 vols. - K.: Zdorovya, 2000. - Vol. 1. - P. 60-95.

28. Vozianova Zh.I., Kovaleva N.M. Differential diagnosis of respiratory infections // Suchasni Infektsiyi. - 2000. - № 2. - P. 11-15.

29. Vozianova Zh.I., Kovaleva N.M. Acute respiratory diseases (clinical features, diagnosis, treatment) // Suchasni Infektsiyi. - 2001. - № 1. - P. 16-22.

30. Vozianova Zh.I., Podolyuk O.A., Golubovskaya O.A. Reliability of the diagnosis of "Influenza" during the seasonal incidence peak // Suchasni Infektsiyi. - 2002. - № 2. - P. 29-32.

31. Vozianova Zh.I., Pechinka A.M. Influenza // Likuvannya ta Diahnostyka. - 2002. - № 2. - P. 23-30.

32. Vozianova Zh.I., Piven V.I., Shestakova I.V. et al. Arbidol in the treatment and prevention of acute respiratory viral diseases // Suchasni Infektsiyi. - 2004. - № 3. - P. 97-100.

33. Vozianova Zh.I., Pechinka A.M. Acute respiratory disease - a problem with many unknowns // Mystetstvo Likuvannya. - 2003. - № 5. - P. 6-11.

34. Vozianov A.F., Butenko A.K. Cytokines. Biological and antitumor properties. - Kyiv: Naukova Dumka, 1998. - 313 p.

35. Volkova M.A. Basic Concepts of interferons // Hepatology and Transfusiology. - 1999. - Vol. 44, № 4. - P. 32-36.

36. Volyansky Yu.L., Sapozhnikov I.G., Zhivitsa M.V. On the antiviral activity of the drug Aflubin // Suchasni Infektsiyi. - 1999. - № 3. - P. 99-101.

37. Vorobyov K.V. Influenza: prevention and treatment. - St. Petersburg: Nevsky Prospekt, 2000. - 146 p.

38. Vorontsova A.L. Pharmacological actions of interferon // "Laferon in the Treatment of Oncological and Infectious Patients": Proc. Sci.-Pract. Conf. - Rivne, 1996. - P. 3-9.

39. Vyadro M.M. CYTOKINES AND THEIR role in the Pathogenesis and therapy of infections // Antibiotics and Chemotherapy. - 1990. - Vol. 35, № 9. - P. 12-16.

40. Gagarinova V.M., Karpukhina O.G., Malikova E.V. et al. Study of the effectiveness of Reaferon in an organized adult community // Reaferon - genetically engineered human alpha-2-interferon. - L., 1988. - P. 53-58.

41. Gagarinova V.M., Ignatyeva G.S., Turyeva A.V. et al. Emergency prophylaxis of influenza and ARD with chemotherapeutic drugs in the nonspecific defense system // Chemotherapy and Chemoprophylaxis of Influenza and ARD. - L., 1990. - P. 109-119.

42. Gagarinova V.M., Ignatyeva G.S., Savitskaya L.V. et al. A new chemotherapeutic drug Arbidol: preventive efficacy during an influenza epidemic // Zhurn. Mikrobiol. - 1993. - № 2. - P. 40-43.

43. Gad S.Ya., Protopopov A.A., Subbotina T.I. Experimental and theoretical substantiation of The Effect of spatial modulation of EHF radiation and its application in biomedical practice // Bulletin of New Medical Technologies. - 2000. - Vol. 7, № 1. - P. 39.

44. Garashchenko T.I., Ilyenko L.I., Garashchenko M.V. Elimination therapy of upper respiratory tract mucous membranes in the prevention of influenza and ARVI // Bulletin of Otorhinolaryngology. - 2004. - № 5. - P. 58-59.

45. Garashchenko T.I., Mezentseva M.V., Ilyenko L.I., Garashchenko M.V. Clinical and immunological rationale for the use of Aflubin in the prevention and treatment of respiratory viral diseases in children // Children's Infections. - 2005. - № 3. - P. 49-53.

46. Gebesh V.V., Litus V.I., Dudar D.M., Topolnytsky V.S. et al. Arbidol - an effective etiotropic drug for influenza // Viral Diseases. Toxoplasmosis. Chlamydiosis: Proc. Sci.-Pract. Conf. and Plenum of the Association of Infectiologists of Ukraine (May 5-6, 2004, Ternopil). - Ternopil: Ukrmedknyha, 2004. - P. 34-36.

47. Gebesh V.V., Topolnytsky V.S., Degtyarenko O.M., Galuzynsky V.P. Efficacy of Grippex in the complex treatment of influenza patients // Viral Diseases. Toxoplasmosis. Chlamydiosis: Proc. Sci.-Pract. Conf. and Plenum of the Association of Infectiologists of Ukraine (May 5-6, 2004, Ternopil). - Ternopil: Ukrmedknyha, 2004. - P. 36-37.

48. Gendon Yu.Z. Live cold-adapted reassortant influenza Vaccines // Vopr. Virusologii. - 2001. - № 3. - P. 5-12.

49. Gendon Yu.Z. Development of mucosal inactivated influenza vaccines // Zhurn. Mikrobiol. - 2003. - № 4. - P. 110-117.

50. Gervazieva V.B. The role of respiratory viruses in The Development of allergy // Cytokines and Inflammation. - 2003. - Vol. 2, № 3. - P. 3-8.

51. Glushkov, R.G., Fadeeva, N.I., Leneva, I.A., et al. (1992). Molecular Biological features of the action of arbidol, a new antiviral drug. Chemical and Pharmaceutical Journal, Vol. 26, no. 2, pp. 10-15.

52. Glushkova, L.I. (2006). Experience in reducing the incidence of influenza in the Komi Republic. In: Infectious Diseases: Public Health and Military Medicine Issues: Proceedings of the Russian Scientific and Practical Conference (March 22-24, 2006). St. Petersburg, p. 75.

53. Grigoriev, K.I., & Zaprudnov, A.M. (2002). Cold-related diseases and hyperthermia. The Attending Physician, no. 9, pp. 30-33.

54. Hryzhak, I.H., & Dykii, B.M. (2001). Pathogenetic therapy of influenza and its complications using the "Grip-Control" drug kit. In: Neuroinfections and Other Infectious Diseases: Proceedings of the Scientific and Practical Conference and Plenum of the Association of Infectiologists of Ukraine (April 26-27, 2001, Kharkiv). Ternopil: Ukrmedknyha, pp. 202-203.

55. Golovleva, I.V. (1989). HUMORAL Immune Response to influenza virus: characterization of the enriched virus-neutralizing fraction of hyperimmune mouse serum. Problems of Virology, no. 2, pp. 150-155.

56. Hrydina, T.L., Lozytskyi, V.P., Fedchuk, A.S., et al. (2005). Anti-influenza properties of unitiol. Odesa Medical Journal, Vol. 87, no. 1, pp. 4-7.

57. Grinbaum, E.B., Litvinova, O.M., Bannikov, A.I., et al. (1994). Polymorphism of the population of modern human influenza A and influenza B viruses. Bulletin of the Russian Academy of Medical Sciences, no. 9, pp. 36-40.

58. (2001). Influenza and ARVI: new approaches to treatment and prevention. The Attending Physician, no. 1: Transl. from English, pp. 15-16.

59. Hromashevska, L.L. (2006). Metabolic intoxication in the pathogenesis and diagnosis of pathological processes. Laboratory Diagnostics, no. 1, pp. 3-6.

60. Guryeva, S.A. (2002). Three-year experience of influenza vaccination. The Attending Physician, no. 9, pp. 30-33.

61. Guchev, I.A., & Klochkov, O.I. (2004). Prevention of Respiratory infection outbreaks in a homogeneous population using dipyridamole. Clinical Medicine, Vol. 82, no. 11, pp. 45-49.

62. Devyatkin, A.V., & Bogomolov, B.P. (2006). State of microcirculation and hemorheology in elderly and senile patients with influenza and other acute respiratory viral infections. In: Infectious Diseases: Public Health and Military Medicine Issues: Russian Scientific and Practical Conference (March 22-24, 2006). St. Petersburg, pp. 94-95.

63. Demikhovska, O.V., & Kovalenko, S.M. (2004). Etiological structure of influenza and ARVI. In: Viral Diseases. Toxoplasmosis. Chlamydiosis: Proceedings of the Scientific and Practical Conference and Plenum of the Association of Infectiologists of Ukraine (May 5-6, 2004, Ternopil). Ternopil: Ukrmedknyha, pp. 66-68.

64. Andreichyn, M.A. (Ed.). (1996). Diagnostics, Therapy, and Prevention of Infectious Diseases in Outpatient Settings. Lviv: Medychna Hazeta Ukrainy, 352 p.

65. Divocha, V.P., Mikelashvili, M.T., & Mikhalchuk, V.N. (2001). Effect of a Trypsin-like protease inhibitor on experimental influenza infection. Infectious Diseases, no. 2, pp. 35-39.

66. Karpukhin, G.I. (Ed.). (2000). Diagnostics, Prevention, and Treatment of Acute Respiratory Diseases. St. Petersburg: Hippokrates, 179 p.

67. Drannik, G.N., Hrynevych, Yu.A., & Dizyk, H.M. (1994). Immunotropic Drugs. Kyiv: Zdorovya, 285 p.

68. Drannik, G.N. (2000). MODERN CONCEPTS OF the Structure and function of The Immune System. Modern Infections, no. 2, pp. 85-101.

69. Drannik, G.N. (2000). Specific acquired (adaptive) Immunity: maturation of T- and B-lymphocytes, INDUCTION OF TOLERANCE, characterization of T-lymphocytes. Modern Infections, no. 3, pp. 96-107.

70. Donina, S.A., Naihin, A.N., Petukhova, G.D., et al. (2006). Systemic humoral and cellular response in experimental influenza infection and vaccination. Medical Immunology, Vol. 8, no. 1, pp. 31-36.

71. Drinevsky, V.P., Osidak, L.V., Afanasyeva, O.I., et al. (2004). A new agent in the combination therapy and prevention of respiratory viral infections. In: Core Issues in Combating Infection: Russian Scientific and Practical Conference (December 1-2, 2004). St. Petersburg, p. 81.

72. Evstropov, A.N., Yavorskaya, V.E., & Golegov, G.A. (1989). Combination of remantadine and 4-iodoantipyrine for the treatment and prevention of experimental influenza infection. Problems of Virology, no. 6, pp. 734-738.

73. Erofeeva, M.K., Shadrin, A.S., Turyeva, A.V., et al. (1986). Evaluation of the effectiveness of emergency influenza prophylaxis agents. In: Nonspecific Agents and Methods for the Prevention of Influenza and Other ARDs. Leningrad, pp. 89-93.

74. Erofeeva, M.K., Maksakova, V.L., Shadrin, A.S., et al. (2000). Evaluation of the efficacy of Immunal for the prevention of influenza and other acute respiratory diseases. Terra Medica, no. 4, pp. 37-39.

75. Erofeeva, M.K., Maksakova, V.L., Kolyvanova, I.L., et al. (2003). Reaferon-ECR-Lipint as an agent for emergency prophylaxis of influenza-like viral diseases. Cytokines and Inflammation, Vol. 2, no. 4, pp. 44-47.

76. Erofeeva M.K., Maksakova V.L., Kolyvanova I.L. et al. [Reaferon-ECR Liposomal Lipint for the prevention of influenza and acute respiratory infections]. Medical Immunology, 2003, vol. 5, no. 3-4, pp. 328-329. (In Russ.)

77. Ershov F.I., Gotovtseva E.P., Lavrukhina L.A. [Interferon status in various diseases]. Problems of Virology, 1990, vol. 35, no. 6, pp. 444-447. (In Russ.)

78. Ershov F.I., Chizhev N.P., Tazulakhova E.P. Antiviral Agents. Saint Petersburg, 1993. 103 p. (In Russ.)

79. Ershov F.I. Antiviral Drugs: A Reference Book. Moscow, Meditsina Publ., 1998. 192 p. (In Russ.)

80. Ershov F.I., Batkaev E.A., Golovkin V.I. et al. Amixin: Application in the Treatment of Acute and Chronic Viral Diseases. Moscow, 1998. 20 p. (In Russ.)

81. Ershov F.I., Tazulakhova E.P. Interferon inducers: A new generation of immunomodulators. Annals of the Russian Academy of Medical Sciences, 1999, no. 4, pp. 52-56. (In Russ.)

82. Ershov F.I., Grigoryan S.S., Semenenko T.A. et al. [The effectiveness of endogenous and exogenous interferonization in influenza prevention]. Journal of Microbiology, Epidemiology and Immunobiology, 1991, no. 10, pp. 42-45. (In Russ.)

83. Ershov F.I. [The Use of immunomodulators in viral infections]. Antibiotics and Chemotherapy, 2003, vol. 48, no. 6, pp. 27-32. (In Russ.)

84. Ershov F.I., Kasyanova N.V., Polonsky V.O. [Is rational pharmacotherapy of influenza and other acute respiratory viral infections possible?]. Infections and Antimicrobial Therapy, 2003, vol. 5, no. 5, pp. 129-134. (In Russ.)

85. Ershov F.I., Narovlyansky A.N., Mezentseva M.M. [Early cytokine responses in viral infections]. Cytokines and Inflammation, 2004, vol. 3, no. 1, pp. 3-6. (In Russ.)

86. Ershov F.I. [Rational pharmacotherapy of influenza and acute respiratory viral infections]. Pharmaceutical Bulletin, 2003, no. 39, pp. 25-29. (In Russ.)

87. Zhogolev S.D., Ogarkov P.I., Zhogolev K.D. et al. [Promising agents and methods for the prevention of community-acquired pneumonia and respiratory infections among military personnel]. Infectious Diseases: Healthcare and Military Medicine Problems: Russian Scientific and Practical Conference (March 22-24, 2006). Saint Petersburg, 2006, pp. 118-119. (In Russ.)

88. Zhuravskaya N.S., Vitkina T.I., Krukovskaya E.A., Natsvasheva T.A. [The method of nasal mucosa scrape-smears in the diagnostics of respiratory diseases]. Clinical Laboratory Diagnostics, 2002, no. 2, pp. 40-42. (In Russ.)

89. Zakharash M.P., Ostaltsev V.F. [The impact of vaccination as a social factor on the Regulation of the epidemic process in influenza and acute respiratory viral infections in certain military formations]. Modern Infections, 2003, no. 4, pp. 112-118. (In Ukr.)

90. Zvartau E.E., Karpov O.I. [The role of pharmacists in preventing severe complications of symptomatic treatment of acute respiratory diseases]. Provisor, 2001, no. 18, pp. 4-6. (In Russ.)

91. Ivanova V.T., Burtseva E.I., Slepushkin A.I. [Variability of hemagglutinin in influenza A (H3N2) virus strains isolated in Russia from 1989 to 1999]. Problems of Virology, 2000, no. 3, pp. 28-31. (In Russ.)

92. Isaeva E.I., Rovnova Z.I. [Duration of detection of influenza virus markers in human Blood lymphocytes]. Ibid., 1994, no. 6, p. 262. (In Russ.)

93. Isakov V.A., Chepik E.B., Shamanova M.G. et al. [Modern approaches to the treatment of severe forms of influenza]. Annals of the Russian Academy of Medical Sciences, 1993, no. 9, pp. 10-13. (In Russ.)

94. Isakov V.A., Shamanova M.G., Nasorina R.N., Chepik E.B. [Clinical and roentgenological features of lung lesions in uncomplicated and pneumonia-complicated influenza]. Annals of the Russian Academy of Medical Sciences, 1995, no. 9, pp. 25-29. (In Russ.)

95. Isakov V.A. [Modern means of symptomatic therapy for influenza and acute respiratory infections]. Terra Medica Nova, 1999, no. 1, pp. 3-5. (In Russ.)

96. Isakov V.A., Kovalenko A.L., Turkin V.V., Aspel Yu.V. The Use of New Immunotropic and Antioxidant Agents in the Therapy of Influenza and Acute Respiratory Infections: A Guide for Physicians. Saint Petersburg, Veliky Novgorod, 2000. 74 p. (In Russ.)

97. Isakov V.A. Clinical and pathogenetic aspects of severe influenza. Allergology and Immunology, 2002, vol. 3, no. 1, pp. 136-144. (In Russ.)

98. Isakov V.A. Modern therapy and Rehabilitation of patients with severe forms of influenza. Allergology and Immunology, 2002, vol. 3, no. 9, pp. 385-389. (In Russ.)

99. Isakov V.A., Erofeeva M.K., Kovalenko A.L. et al. [The use of Cycloferon in the therapy of influenza and acute respiratory infections]. International Medical Journal, 2002, no. 2, pp. 529-532. (In Russ.)

100. Isakov V.A., Maksakova V.L., Chepik E.B. [Efficacy of Cycloferon tablets in the therapy of influenza and acute respiratory infections]. The Practitioner, 2000, no. 8, pp. 46-47. (In Russ.)

101. Interferonogenic activity of antibiotics / S.L. Rybalko, V.A. Dieiev, O.V. Pokas et al. // Proceedings in Memory of L.V. Hromashevsky "Problems of Epidemiology, Diagnostics, Clinic, Treatment, and Prevention of Infectious Diseases". - K., 2002. - P. 396-398.

102. Kabalova I.V., Isakov V.A. Complex therapy of influenza // Infectious Diseases: Healthcare and Military Medicine Problems: Proc. Sci.-Pract. Conf. (22-24.03.2006). - SPb, 2006. - P. 140-141.

103. Kamyshentsev M.V., Stefanov V.E. Influenza: A Way to Solve the Problem. - SPb: Hippocrates, 2002. - 240 p.

104. Karaulov A.V., Sokurenko S.I., Barmotin G.V. Principles of immunotherapy and immunorehabilitation in recurrent respiratory diseases // Lech. Vrach. - 2000. - No. 1. - P. 44-45.

105. Karpukhin G.I. Influenza. - SPb: Hippocrates, 2001. - 359 p.

106. Karpukhin G.I. Acute Non-Influenza Respiratory Infections. - SPb: Hippocrates, 1996. - 320 p.

107. Ketlinsky S.A., Simbirtsev A.S., Vorobyov A.A. Endogenous Immunomodulators. - SPb: Hippocrates, 1992. - 255 p.

108. Ketlinsky S.A., Kalinina N.M. Cytokines of mononuclear phagocytes in The regulation of inflammation and immunity // Immunology. - 1995. - No. 3. - P. 30-43.

109. Kidalov V.N., Khadartsev A.A., Yakushina G.N. Systemic effects of EHF exposure in the treatment of patients with bronchoobstructive syndrome // Bulletin of New Medical Technologies. - 2001. - Vol. 8, No. 4. - P. 72-74.

110. Kiselev O.I., Isakov V.A., Sharonov B.P., Sukhinin V.P. Pathogenesis of severe forms of influenza // Bulletin of the RAMS. - 1995. - No. 9. - P. 32-36.

111. Kiselev O.I., Deyeva E.G., Slita A.V. et al. Antiviral drugs for the treatment of influenza and ARD. Drug design based on polymeric carriers. - SPb: 2002. - 132 p.

112. Kyrychek L.T. Antibiotics in modern chemotherapy // Intern. Med. J. - 2003. - Vol. 9, No. 1. - P. 118-122.

113. Kladova O.V., Shamsheva O.V. Results of topical IRS-19 lysate application in the treatment of acute respiratory infections in children // Children's Infections. - 2005. - No. 3. - P. 44-46.

114. Klochkov O.I., Guchev I.A., Ivanitsa G.V. Clinical consequences of azithromycin prophylaxis for respiratory tract infections in organized groups // Military-Medical Journal. - 2004. - Vol. 325, No. 11. - P. 43-47.

115. Kozlovsky M.M., Benzel L.V., Lozynsky I.M. et al. New promising interferon inducers of plant origin // Clinical Problems of Combating Infectious Diseases: Proc. VI Congress of Infectiologists of Ukraine (September 25-27, 2002, Odesa). - Ternopil: Ukrmedknyha, 2002. - P. 306-307.

116. Kozko V.M., Katsapov D.V. Influenza A: antigenic variation, virulence, prevention // Vracheb. Praktika. - 2000. - No. 1. - P. 29-32.

117. Kozko V.M., Katsapov D.V., Hradil H.I. Clinical and laboratory evaluation of cell membrane status in pneumonia complicating influenza and acute respiratory viral infections // Lab. Diagnostics. - 2000. - No. 3. - P. 17-20.

118. Kozko V.M., Hradil H.I., Katsapov D.V. Etiological structure of acute respiratory diseases in the Kharkiv region // Neuroinfections. Other Infectious Diseases: Proc. Sci.-Pract. Conf. and Plenum of the Association of Infectiologists of Ukraine (April 26-27, 2001, Kharkiv). - Ternopil: Ukrmedknyha, 2001. - P. 216-217.

119. Kozko V.M., Krasnov M.I., Katsapov D.V. Experience in using Antiviral Therapy for the prevention and treatment of influenza and acute respiratory viral infections // Vracheb. Praktika. - 2004. - No. 1. - P. 28-32.

120. Kozko V.M., Mohylynets O.I., Hradil H.I., Katsapov D.V. Application of interferon inducers in the complex treatment of patients with acute respiratory diseases // Vracheb. Praktika. - 2006. - No. 1. - P. 27-30.

121. Kolobukhina L.V., Gatich R.Z., Merkulova N.L. et al. Complex treatment of ARVI complicated by tonsillitis // Lech. Vrach. - 2003. - No. 1. - P. 24-25.

122. Kolodiy M.A. Clinical and epidemiological features of diagnostics, treatment, and prevention of adenoviral infection in organized groups // Infectious Diseases. - 2000. - No. 4. - P. 79-80.

123. Kononenko V.V. Experience in using oseltamivir (Tamiflu) in the treatment of influenza // Chemotherapy and Immunocorrection of Infectious Diseases: Proc. Sci.-Pract. Conf. and Plenum of the Association of Infectiologists of Ukraine (May 30 - June 1, 2005, Ternopil). - Ternopil: Ukrmedknyha, 2005. - P. 48-50.

124. Kostinov M.P., Kostinova T.A., Magarshak O.O., Esman V.N. Efficacy of emergency and scheduled influenza vaccine prophylaxis // Lech. Vrach. - 2002. - No. 10. - P. 38-40.

125. Kostrova O.M., Aleshkin V.A. IMMUNOGLOBULINS for the prevention and treatment of viral infections // Immunology. - 1995. - No. 6. - P. 6-7.

126. Kramaryov, S.O., Maltsev, V.I., & Kazymyrko, V.K. (2003). Gripferon as an effective agent for the prevention and treatment of influenza and other ARVI. Infektsiyni Khvoroby, 1, 70-72.

127. Kramarev, S.A., Palatnaya, L.A., & Litus, V.I. (2003). Experience with arbidol in the treatment and prevention of influenza and acute respiratory viral infections in children in Ukraine. RMZh, 11(21), 17-20.

128. Krylov, V.F. (1990). Clinical presentation and differential diagnosis of influenza and other acute respiratory viral diseases. Klinicheskaya Meditsina, 8, 111-115.

129. Kuznetsov, S.M., Smirnov, N.A., & Latash, V.I. (2003). Effect of Interferon Therapy on the interferon status of patients and the functional activity of certain blood cell populations. Medical Immunology (Russia), 5(1-2), 73-80.

130. Kutsenok, V.A. (1993). Information-Wave Therapy: Methodological Manual. Kyiv, 114 p.

131. Litvinova, O.M., Grinbaum, E.B., Bannikov, A.I., et al. (1995). Characteristics of interepidemic influenza A and B viruses. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, 9, 32-36.

132. Libina, V., Tymchenko, O., & Zadorozhna, N. (2003). Grippocid capsules: a new domestic complex medication for the treatment of respiratory diseases. Vranebnaya Praktika, 1, 107-108.

133. Lobzin, Yu.V., & Zakharov, V.I. (1994). Rehabilitation and Clinical Dispansaerization of Infectious Patients. St. Petersburg: Hippocrates, 214 p.

134. Lobzin, Yu.V., Mykhailenko, V.P., & Lvov, N.I. (2000). Airborne Infections. St. Petersburg, 94 p.

135. Lobzin, Yu.V., & Lvov, N.I. (2001). Interferon inducers in the therapy of acute respiratory diseases: challenges and Prospects. Military Medical Journal, 322(11), 41-50.

136. Lobzin, Yu.V., Lvov, N.I., & Kolokoltsov, A.A. (2004). Liposomal Reaferon-ES-Lipint in the treatment of patients with influenza and other acute respiratory diseases. Cytokines and Inflammation, 3(1), 49-54.

137. Lozytsky, V.P., Hrydyna, T.L., Fedchuk, A.S., et al. (2006). Antiviral activity of official preparations of S-aminocaproic acid and unitiol against avian influenza virus. Odesa Medical Journal, 95(3), 4-8.

138. Loskutova, I.V., Shapovalova, I.O., Tereshyn, V.O., & Sotska, Ya.A. (2002). Evaluation of the efficacy of amizon in the clinical practice of an infectious disease specialist. In Clinical Problems of Combating Infectious Diseases: Proceedings of the 6th Congress of Infectious Disease Specialists of Ukraine (September 25-27, 2002, Odesa) (pp. 318-320). Ternopil: Ukrmedknyha.

139. Lukianova, O., Kovalchuk, O., & Spivak, M. (2001). Interferon status parameters in children with acute and recurrent bronchopulmonary pathology and the use of recombinant a2-interferon (laferon) in combination therapy. Liky, 1, 59-60.

140. Lutai, T., & Lasytsia, T. (2003). Acute respiratory viral infections: diagnostic and treatment features. Liky Ukrainy, 11, 65-66.

141. Luchikhin, L.A. (2002). ARVI: modern approaches to treatment and prevention. Lechaschiy Vrach, 1-2, 12-16.

142. Lvov, N.I., Pak, N.N., Voytsekhovskaya, E.M., et al. (2002). Effect of amixin on serum interferon activity in acute respiratory diseases. Medical Immunology (Russia), 4(2), 242-243.

143. Lvov, D.K., Slepushkin, A.N., Yamnikova, S.S., & Burtseva, E.I. (1998). Influenza remains an unpredictable infection. Problems of Virology, 3, 141.

144. Lvov, N.I. (2004). Clinical presentation of influenza A in young adults from organized communities. In Key Issues in Combating Infection: Russian Scientific and Practical Conference (December 1-2, 2004) (p. 151). St. Petersburg.

145. Lvov, N.I., Pak, N.N., Misnikov, O.P., et al. (2004). State of the body's nonspecific defense in patients with influenza A. In Ibid. (p. 151). St. Petersburg.

146. Lvov, N.I. (2003). Comparative characteristics of cellular immunity in influenza A and influenza B. Medical Immunology (Russia), 5(3-4), 304-305.

147. Liashevych, O.M. (2001). Correlation between the intensity of individual environmental factors and the incidence of acute respiratory viral infections in children. Infektsiyni Khvoroby, 2, 39-43.

148. Lyashchenko, V.A. (1995). Macrophages in the infectious process. Immunologiya, 4, 48-58.

149. Malashenkova, I.K., Tazulakhova, E.B., & Didkovsky, N.A. (1998). Interferons and inducers of their synthesis (Review). Therapeutic Archive, 11, 35-39.

150. Malashkin, A.B., Romantsov, M.G., & Malyshkin, K.A. (2000). Cycloferon as a means of enhancing nonspecific resistance in respiratory diseases in children. Lechaschiy Vrach, 9, 48-50.

151. Malinovskaya V.V., Zakharova I.N., Korovina N.A. et al. The use of domestic interferons in infectious and inflammatory respiratory diseases in children // Int. J. Med. Pract. - 2000. - № 6. - P. 71-72.

152. Marinich I.G., Paramonova M.S., Erofeeva M.K. et al. Influenza immunoprophylaxis among the elderly // J. Microbiol. - 1997. - № 3. - P. 60-64.

153. Marinich I.G., Timoshenko O.F., Ignatieva G.S., Morozov I.V. Mortality from influenza, other acute respiratory diseases, and acute pneumonia // Vaktsinatsiya. - 1999. - № 5. - P. 4-5.

154. Marinich I.G., Boldasov V.K., Ignatieva G.S. et al. CHARACTERISTICS OF THE influenza epidemic globally, in Russia, and in the CIS countries during the 1987-1998 season // J. Microbiol. - 1999. - № 5. - P. 89-94.

155. Markelova E.V., Prosekova E.V., Nedobylsky O.V. The role of cytokines in the pathogenesis of pneumonia // Med. Immunol. - 2000. - Vol. 2, № 4. - P. 369-375.

156. Markin V.A. Nonspecific antiviral drugs: expectations and realities (literature review) // Military Med. J. - 2000. - № 8. - P. 51-60.

157. Markov I.S. Clinical and epidemiological efficacy of emergency influenza prophylaxis with the Influvac vaccine in Kyiv, January–February 1999 // Infectious Diseases. - 1999. - № 4. - P. 39-43.

158. Masychova V.I., Fadina V.A., Danilenko E.D. Activation of phagocytosis by recombinant human tumor necrosis factor beta // Antibiotics and Chemotherapy. - 2000. - № 6. - Vol. 45. - P. 21-24.

159. Matyushichev V.B., Potapenko A.A., Dementiev A.A., Sokolov I.N. A method of antibody purification for immunofluorescence diagnosis of influenza // Clin. Lab. Diagnostics. - 2002. - № 2. - P. 19-21.

160. Melnikov O.A., Averkieva L.V. Modern drugs for the treatment of ARVI and influenza // Lech. Vrach. - 2004. - № 8: Transl. from English. - P. 40-44.

161. Mironenko A.P. Problems of anti-influenza immunity // J. Pract. Physician. - 2000. - № 3. - P. 49-50.

162. Mironenko A.P. The state of specific influenza prophylaxis in Ukraine and some of its economic aspects // Modern Infections. - 2001. - № 2. - P. 117-119.

163. Mironenko, A.P., & Mukhopad, V.O. (2001). Strategies and stages of influenza control. Infektsiini khvoroby, 2, 55-58.

164. Mironenko, A.P., Kolmogorov, O.V., & Ostapchuk, P.M. (2001). Influenza control in industrial enterprises through vaccine prophylaxis. Suchasni infektsii, 3, 155-158.

165. Mironenko, A.P., Khmelnytska, G.S., Kolmogorov, O.V., & Ostapchuk, P.M. (2002). Efficacy of influenza vaccine prophylaxis among high-risk groups. Suchasni infektsii, 2, 125-128.

166. Mineyev, V.N. (2006). Immunocorrection with polyoxidonium in the prevention of influenza and acute respiratory viral infections. Klinicheskaya farmakologiya, 2, 91-94.

167. Mikheyev, S.M. (2000). Vaccine prophylaxis of acute respiratory viral infections. Rus. med. zhurnal, 8(17), 730-731.

168. Moskalyuk, V.D., & Biletska, K.V. (2003). Acute respiratory diseases in Bukovyna. In Controlled Infections: Proceedings of the Scientific and Practical Conference and Plenum of the Association of Infectious Diseases Physicians of Ukraine (May 14-15, 2003, Ivano-Frankivsk) (pp. 280-281). Ternopil: Ukrmedknyha.

169. Moskalyuk, V.D. (2003). Practical approaches to the treatment of influenza and other acute respiratory viral infections. Infektsiini khvoroby, 2, 100-104.

170. Moskalyuk, V.D. (2003). New approaches to the treatment of acute respiratory viral infections. Bukovynskyi medychnyi visnyk, 1, 91-93.

171. Moskalyuk, V.D., Trefanenko, A.G., Bohachyk, N.A., & Venhlovska, Ya.V. (2004). Improvement of treatment for influenza and other acute respiratory viral infections. In Viral Diseases. Toxoplasmosis. Chlamydiosis: Proceedings of the Scientific and Practical Conference and Plenum of the Association of Infectious Diseases Physicians of Ukraine (May 5-6, 2004, Ternopil) (pp. 19-21). Ternopil: Ukrmedknyha.

172. Moskalyuk, V.D., Trefanenko, A.G., Venhlovska, Ya.V., & Bohachyk, N.A. (2004). Optimization of treatment for influenza and other acute respiratory viral infections. In Dynamics of Scientific Research, 2004: Proceedings of the III International Scientific and Practical Conference (pp. 42-43). Dnipropetrovsk: Nauka i osvita.

173. Moskalyuk, V.D. (2004). Etiological structure and clinical-epidemiological features of acute respiratory viral infections in organized communities. Klinichna ta eksperymentalna patolohiya, 3(I), 53-55.

174. Moskalyuk, V.D. (2004). Laferon in the complex treatment of patients with influenza A. Infektsiini khvoroby, 1, 32-34.

175. Moskalyuk, V.D. (2004). Comparative characteristics of the cellular immunity status in influenza A and influenza B. In Proceedings of the 10th Congress of the World Federation of Ukrainian Medical Societies (p. 419). Chernivtsi-Kyiv-Chicago.

176. Moskaliuk V.D. Efficacy of proteflazid in patients with influenza and other acute respiratory viral infections // Bukovinian Medical Herald. - 2004. - № 2. - P. 161-164.

177. Moskaliuk V.D. Clinical and epidemiological characteristics of influenza A in an organized community during the 2003 epidemic // Infectious Diseases. - 2003. - № 4. - P. 40-42.

178. Moskaliuk V.D., Sokol A.M. Treatment of patients with ARVI: achievements and prospects // Infectious Diseases. - 2004. - № 4. - P. 5-10.

179. Moskaliuk V.D. Cardiovascular system changes in patients with respiratory syncytial infection // Infectious Diseases. - 2005. - № 2. - P. 28-31.

180. Moskaliuk V.D. Endogenous intoxication of the body in patients with acute respiratory viral infections // Archives of Clinical Medicine. - 2005. - № 1. - P. 48-50.

181. Moskaliuk V.D., trefanenko A.G., Bohachyk N.A., Venhlovska Ya.V., Balabash V.M., Feldman L.Ya. Complex therapy of patients with influenza A // Chemotherapy and Immunocorrection of Infectious Diseases: Proceedings of the Scientific and Practical Conference and Plenum of the Association of Infectiousists of Ukraine (May 30 - June 1, 2005, Ternopil). - Ternopil: Ukrmedknyha, 2005. - P. 63-64.

182. Moskaliuk V.D. New technologies in the treatment of ARVI // Infectious Diseases. - 2004. - № 1. - P. 28-31.

183. Moskaliuk V.D. The use of laferon in the treatment of ARVI // Infectious Diseases. - 2006. - № 1. - P. 10-12.

184. Moskaliuk V.D., Andreychyn M.A. Adenovirus infection: clinical and epidemiological features in military personnel // Bukovinian Medical Herald. - 2006. - Vol. 10, № 3. - P. 57-59.

185. Moskaliuk V.D. Features of the course of influenza B in adults // Clinical and Experimental Pathology. - 2006. - Vol. 5, № 1. - P. 62-64.

186. Moskaliuk V.D. Respiratory syncytial infection in an organized community: clinical and epidemiological characteristics // Infectious Diseases. - 2006. - № 3. - P. 36-38.

187. Moskaliuk V.D., Khomko L.P. EHF therapy in the complex treatment of patients with adenovirus and respiratory syncytial infections // Halych Medical Herald. - 2006. - Vol. 13, № 3. - P. 57-58.

188. Moskaliuk V.D. Electrocardiogram changes in patients with acute respiratory viral infections // Bukovinian Medical Herald. - 2006. - Vol. 10, № 2. - P. 43-45.

189. Moskaliuk V.D., Andreychyn M.A. Dynamics of cellular immunity indicators in patients with acute respiratory infections of unspecified etiology under METABOLISM/18.html">The Influence of various treatment methods // Bukovinian Medical Herald. - 2006. - Vol. 10, № 3. - P. 57-59.

190. Moskaliuk V.D. Changes in cellular immunity in patients with acute respiratory diseases of unspecified etiology under the influence of complex treatment // Clinical and Experimental Pathology. - 2006. - Vol. 5, №. 2. - P. 62-66.

191. Moskaliuk V.D. Effect of laferon on the dynamics of serum interferon changes and cellular immunity indicators in patients with adenovirus infection // Infectious Diseases. - 2006. - № 2. - P. 40-42.

192. Moskaliuk V.D. Application of EHF therapy in the complex treatment of patients with influenza A // Modern Infections. - 2006. - № 1-2. - P. 11-14.

193. Moskaliuk V.D., Bohachyk N.A., Trefanenko A.G., Venhlovska Ya.V., Paduraru Yu.O., Nesterovska T.I. Clinical and epidemiological characteristics of influenza A in an organized community // Infectious Diseases as a General Medical Problem: Proceedings of the VII Congress of Infectiousists of Ukraine (September 26-29, 2006, Myrhorod). - Ternopil: Ukrmedknyha, 2006. - P. 293-294.

194. Moskaliuk V.D., Trefanenko A.G., Bohachyk N.A., Venhlovska Ya.V. Laferon and proteflazid in the complex treatment of patients with influenza and other ARVI // Infectious Diseases as a General Medical Problem: Proceedings of the VII Congress of Infectiousists of Ukraine (September 26-29, 2006, Myrhorod). - Ternopil: Ukrmedknyha, 2006. - P. 297-298.

195. Moskaliuk V.D., Bohachyk N.A., Venhlovska Ya.V. Efficacy of aerosol interferon therapy in combination with Proteflazid in influenza A and B // Bukovinian Medical Herald. - 2007. - Vol. 11, № 1. - P. 47-49.

196. Moskaliuk V.D. Experience in treating patients with influenza B // Infectious Diseases. - 2007. - № 1. - P. 18-21.

197. Moskaliuk V.D. Effect of nebulizer laferon therapy on the dynamics of cellular immunity changes in patients with influenza A // Modern Infections. - 2007. - № 3-4. - P. 53-57.

198. Nagoev B.S., Orazaev N.G. Indicators of the spontaneous nitroblue tetrazolium test in influenza patients // Therapeutic Archive. - 2000. - Vol. 72, № 11. - P. 24-27.

199. Nagoev B.S., Orazaev N.G. Some immunity indicators in influenza patients // Infectious Diseases: Problems

of Public Health and Military Medicine: Russian Scientific and Practical Conference (March 22-24, 2006). - St. Petersburg, 2006. - P. 224.

200. Naykhin A.M., Artemyeva S.A., Bosak L.V., Katorgina L.G. The Significance of functional activity of antibodies in anti-influenza immunity // Vestn. RAMN. - 1995. - № 9. - P. 32-36.

201. Naykhin A.M., Donina S.A., Kustikova Yu.G. et al. Study of post-vaccination immunity to influenza A and B viruses in enzyme immunoassay using the developed monoclonal enzyme immunoassay test system // Vopr. virusol. - 1997. - № 6. - P. 271-275.

202. Nazarov P.G., Butyugov A.A., Freydlin I.S. et al. Antitoxic activity of the analgesic "Panadol" // Meditsina Ukrainy. - 1996. - № 3. - P. 49-50.

203. Namazova L.S., Voznesenskaya N.I. Acute respiratory infections in children // Lech. Vrach. - 2002. - № 1-2. - P. 4-7.

204. Nikitin E., Kulchitskaya O., Fedorenko T., Karpinchik V. Antiviral therapy in the infectious disease clinic // Liki Ukrainy. - 2000. - № 11. - P. 40-41.

205. Nikitin E., Kulchitskaya O., Fedorenko T., Karpinchik V. Antiviral therapy in the infectious disease clinic // Liki Ukrainy. - 2001. - № 1. - P. 27-28.

206. Nikolayev A.M. Mechanism of efficacy of first-generation antihistamines in acute respiratory viral infections // Apteka Halytska. - 2003. - № 2. - P. 13-14.

207. Novikov D.K. Antiviral immunity // Immunopatologiya. - 2002. - № 1. - P. 5-15.

208. Nosach L. Current state of antiviral chemotherapy // Visnyk farmakolohiyi ta farmatsiyi. - 2004. - № 2. - P. 6-10.

209. Obraztsova E.V., Golovacheva E.G., Dondurey E.A. et al. Interferons and interferon inducers in the treatment of influenza and other acute respiratory viral infections // Infectious Diseases: Public Health and Military Medicine Issues: Russian Scientific-Practical Conference (March 22-24, 2006). - St. Petersburg, 2006. - P. 235.

210. Obrosova-Serova N.P., Burtseva E.I., Nevsky I.M. et al. Influence of the protective effect of arbidol during the rise in respiratory diseases in 1990 // Vopr. virusol. - 1991. - № 5. - P. 380-381.

211. Ostrovsky N.N., Belova E.G. Acute respiratory diseases // Ibid. - 2001. - № 8. - P. 26-28.

212. Orazaev N.G. Content of middle-molecule Peptides in influenza patients // Key Issues in Combating Infection: Russian Scientific-Practical Conference (December 1-2, 2004), St. Petersburg, 2004. - P. 179.

213. Pastushenkov L.V., Pastushenkov A.L., Pastushenkov V.L. et al. Medicinal Plants. - St. Petersburg, 1998. - 382 p.

214. Patent 68219 A. Ukraine, IPC 7 A61P31/12. Method of treatment of acute respiratory viral infections / V.D. Moskalyuk. - № 20031110511; Declared 21.11.2003; Publ. 15.07.2004, Bul. № 7. - 3 p.

215. Pashchenkov M.V., Pinegin B.V. The role of dendritic Cells in the regulation of the immune response // Immunologiya. - 2002. - № 5. - P. 313-320.

216. Pestun I., Tolochko V. Pharmacoeconomic studies of immunity-stimulating drugs // Liki. - 2002. - № 1. - P. 20-22.

217. Pestun I., Tolochko V. Pharmacoeconomic studies of immunity-stimulating drugs // Ibid. - 2002. - № 2. - P. 14-16.

218. Petrukh L.I. A new pharmacological antiviral agent // Clinical Problems of Combating Infectious Diseases: Proceedings of the VI Congress of Infectiologists of Ukraine (September 25-27, 2002, Odesa). - Ternopil: Ukrmedknyha, 2002. - P. 353-355.

219. Petrov R.V., Khaitov R.M., Pinegin B.V. Assessment of human immune status in normal and pathological conditions // Immunologiya. - 1994. - № 6. - P. 6-10.

220. Petrosyan V.I., Gulyaev Yu.V., Zhiteneva E.A. Interaction of physical and biological objects with extremely high frequency electromagnetic radiation // Radiotekhnika i Elektronika. - 1995. - Vol. 40, № 1. - P. 127-134.

221. Pechinka A.M., Shkurba A.V. Acute respiratory diseases: etiology, diagnostic approaches, treatment // Suchasni Infektsiyi. - 2005. - № 3-4. - P. 92-100.

222. Pinegin B.V. Principles of using immunomodulators in the complex treatment of infectious processes // Lech. Vrach. - 2000. - № 8. - P. 34-38.

223. Podchernyaeva R.Ya., Isaeva E.I., Smirnova V.V., Mezentseva M.V. Study of the anti-influenza drug Influcid // Key Issues in Combating Infection: Russian Scientific-Practical Conference (December 1-2, 2004), St. Petersburg, 2004. - P. 192.

224. Pokrovskaya E.E., Osidak L.V., Drinevsky V.P. et al. Immune replacement therapy in RSV infection // Vestn. RAMN. - 1995. - № 9. - P. 43-45.

225. Popov V.F. Drug forms of interferons. - M.: Triada-H, 2002. - 136 p.

226. Proteflazid. Information Materials on properties and application methods. - Kyiv, 2002. - 69 p.

227. Rudenko A.A., Muravskaya L.V., Parkhomets B.A. Post-influenza complications // Zhurn. prakt. vracha. - 1997. - № 1. - P. 10-13.

228. Rudenko A.O., Muravska L.V., Parkhomets B.A. Clinical and Laboratory studies in the treatment of influenza and its complications with the drug Anti-Flu // Infektsiini khvoroby. - 1999. - № 3. - P. 55-56.

229. Rudenko A.A. Immunological aspects, pathogenesis, diagnosis, treatment of influenza and acute respiratory infections // Zhurn. prakt. likaria. - 1999. - № 4. - P. 2-4.

230. Rudenko A.A., Burchinsky S.G. Clinical and pharmacological aspects of early therapy for influenza and other ARVI // Ibid. - 2001. - № 4. - P. 39-41.

231. Rudenko A., Spivak M., Ganova L. et al. Interferon preparations in the complex therapy of INFECTIOUS DISEASES OF bacterial etiology // Liky Ukrainy. - 2001. - № 2. - P. 36-41.

232. Rudenko A.O., Rybalko S.L., Dyadyun S.T. et al. Clinical and experimental studies of isoprinosine in influenza // Collection of scientific-practical and experimental works. - K., 2002. - P. 19-22.

233. Rudenko A.A., Rader A.S., Karpinchik V.A. Fighting influenza easily and cheaply // Zdorovia Ukrainy. - 2005. - № 4. - P. 45.

234. Rumel N.B., Golovacheva E.G., Osidak L.V. The role of specific secretory and serum antibodies in acute respiratory diseases of various etiologies in children // Med. immunologiya. - 2003. - Vol. 5, № 5-6. - P. 609-614.

235. Samosyuk I.Z. Millimeter-wave electromagnetic therapy (ELF therapy, MRT, MVT) // Scientific and practical materials on the application of physical factors in clinical and spa practice. Iss. 1. - Kyiv, 1998. - 125 p.

236. Samosyuk I.Z. Millimeter-wave electromagnetic therapy (ELF therapy, MRT, MVT) // Scientific and practical materials on the application of physical factors in clinical and spa practice. Iss. 1-2. - Kyiv. - 1999. - 199 p.

237. Selkova E.P., Yakovlev V.N., Semenenko T.A. et al. Evaluation of the prophylactic effect of amixin against acute respiratory viral infections // Mikrobiologiya. - 2000. - № 1. - P. 42-46.

238. Selkova E.P. Nonspecific prevention of influenza and ARVI with the domestic drug amixin // Lech. vrach. - 2000. - № 1. - P. 49.

239. Selkova E.P., Gracheva I.Yu., Gotvyanskaya T.P. et al. Study of the immunomodulating activity of arbidol // RMZh. - 2001. - Vol. 9, № 16-17. - P. 34-36.

240. Selkova E.P., Semenenko T.A., Nosik N.A. The effect of amixin - a domestic analog of tilorone - on human interferon and immune status indicators // Ibid. - 2001. - № 4. - P. 31-35.

241. Selkova E.P., Uchaikin V.F., Shumilov V.I. et al. Organizational and methodological approaches to improving the prevention and treatment of influenza and other ARVI // RMZh. - 2002. - Vol. 2. - P. 3-7.

242. Selkova E.P., Ershov F.I. Epidemiological efficacy of cycloferon during periods of increased respiratory morbidity // Vrach. - 2003. - № 11. - P. 56-57.

243. Selkova E., Botvinieva V., Zhekalov A. et al. Efficacy of cycloferon for the prevention and treatment of acute respiratory viral infections based on multicenter studies in various population categories // Bulletin of the Saint Petersburg State I.I. Mechnikov Medical Academy. - 2004. - № 1. - P. 156-159.

244. Selkova E.P., Nikitina G.Yu. Nonspecific prevention of acute respiratory viral diseases with poludan // VI Russian-Italian Scientific Conf. "Infectious diseases: diagnosis, treatment, prevention" (December 14-16, 2000), SPb. - P. 230.

245. Selkova E.P., Nikitina G.Yu. Efficacy of amixin in the prevention of ARVI // VI Russian-Italian Scientific Conf. "Infectious diseases: diagnosis, treatment, prevention" (December 14-16, 2000), SPb. - P. 230-231.

246. Selkova E.P., Pantyukhova T.N., Turyanov M.Kh. Application of amixin for the treatment of ARVI // VI Russian-Italian Scientific Conf. "Infectious diseases: diagnosis, treatment, prevention" (December 14-16, 2000), SPb. - P. 231.

247. Selkova E.P., Semenenko T.A., Nikitina G.Yu., Pantyukhova T.N. Study of the immunological efficacy of amixin // Ibid. - P. 232.

248. Semenov B.F., Gervazieva V.B., Sveranovskaya V.V. Prevalence and structure of acute respiratory viral infections // Zhurn. mikrobiol. - 2002. - № 5. - P. 79-86.

249. Semenenko T.A., Selkova E.P., Gendon Yu.Z. Specific prevention of influenza with an inactivated split vaccine Vaxigrip // Zhurn. mikrobiol.- 2004. - № 4. - P. 109-113.

250. Semenenko, T.A., Selkova, E.P., Uchaikin, V.F., et al. MECHANISM OF ACTION, clinical and epidemiological efficacy, and prospects of arbidol use in influenza and acute respiratory viral infections. Infectious Diseases, 2006, vol. 4, no. 1, pp. 58-62.

251. Serebryana, N.B., & Ketlinsky, S.A. The role of type I interferons in the regulation of the immune system. Medical Academic Journal, 2004, vol. 4, no. 2, pp. 3-18.

252. Simbirtsev, A.S. Cytokines as a novel system for regulating the body's defense reactions. Cytokines and Inflammation, 2002, vol. 1, no. 1, pp. 9-17.

253. Simbirtsev, A.S. Cytokines: Classification and biological Functions. Cytokines and Inflammation, 2004, vol. 3, no. 2, pp. 16-21.

254. Skachkov, M.V., Smolyagin, A.I., Boev, V.M., et al. Immunological efficacy of vaccination in various environmental settings. Epidemiology and Infectious Diseases, 2001, no. 4, pp. 47-48.

255. Skolibog, S.A., Kolmogorov, A.V., & Spiridonova, T.B. Experience in controlling an influenza epidemic through specific immunoprophylaxis at a large industrial enterprise. Modern Infections, 2002, no. 3, pp. 120-123.

256. Slepushkin, A.N., Lvov, D.K., Marinich, I.G., et al. Epidemiological features of influenza in recent years. Problems of Virology, 1998, no. 2, pp. 59-62.

257. Slepushkin, A.N., & Vlasova, L.N. Prevention of influenza and acute respiratory viral infections. Russian Medical Journal, 2001, vol. 9, no. 16-17, pp. 45-37.

258. Slobodenyuk, A.V., Grigorieva, Yu.V., & Pashnina, N.Ya. Mechanisms of the protective action of the herbal preparation erakond in influenza. Journal of Microbiology, 2003, no. 1, pp. 78-80.

259. Sukhinin, V.P., Zarubaev, V.V., Platonov, V.G., et al. Protective effect of cycloferon in experimental influenza infection. Problems of Virology, 2000, vol. 45, no. 5, pp. 26-30.

260. Sysoyeva, G.M., Masycheva, V.I., & Danilenko, E.D. Prospects for Using interferon inducers in the treatment and prevention of influenza and acute respiratory viral infections. Bulletin of the Russian Academy of Medical Sciences, 2004, no. 11, pp. 33-38.

261. Tambiev, A.Kh., & Kirikova, N.N. Some new concepts regarding the causes of the stimulatory effects of ELF-EHF radiation. Biomedical Electronics, 2000, no. 1, pp. 23-33.

262. Tazulakhova, E.B., Parshina, O.V., Guseva, T.S., et al. New approaches to screening interferon inducers. Journal of Microbiology, 1994, no. 6, pp. 91-93.

263. Tatochenko, V.K. On influenza vaccination. Attending Physician, 2001, no. 8, pp. 20-25.

264. Techniques and Methods of Physiotherapeutic Procedures / Ed. by V.M. Bogolyubov. Moscow: Meditsina, 2002. 408 p.

265. Turishchev, S.N. Herbal remedies for acute respiratory viral infections. Pharmacy, 2002, no. 5, pp. 47-48.

266. Tretyakevich, Z.M., & Lysenko, O.A. Efficacy of amizon in the treatment of frequently ill children with ARVI. Neuroinfections and Other Infectious Diseases: Proceedings of the Scientific and Practical Conference and Plenum of the Association of Infectious Diseases Specialists of Ukraine (April 26-27, 2001, Kharkiv). Ternopil: Ukrmedkniga, 2001, pp. 264-265.

267. Physiological Mechanisms of BIOLOGICAL EFFECTS OF Low-Intensity EHF EMF / E.N. Chuyan, I.A. Temuryants, O.B. Moskovchuk, et al. Simferopol: Elinyo PE, 2003. 448 p.

268. Freidlin, I.S. The key position of macrophages in the cytokine regulatory network. Immunology, 1995, no. 3, pp. 44-48.

269. Freidlin, I.S. The Immune System and Its Defects. Saint Petersburg: Polisan, 1998. 156 p.

270. Freidlin, I.S. Regulatory T cells: origin and functions. Medical Immunology, 2005, vol. 7, no. 4, pp. 347-354.

271. Frolov, A.F., Frolov, V.M., & Loskutova, I.V. Amizon: Experience of clinical use of a new Ukrainian drug. Ukrainian Medical Journal, 2000, no. 1, pp. 78-80.

272. Frolov, A.F., & Frolov, V.M. Efficacy of amizon in the therapy and prevention of viral infections. Neuroinfections and Other Infectious Diseases: Proceedings of the Scientific and Practical Conference and Plenum of the Association of Infectious Diseases Specialists of Ukraine (April 26-27, 2001, Kharkiv). Ternopil: Ukrmedkniga, 2001, pp. 267-269.

273. Frolov, A.F., & Aronova, M.M. Characteristics of the influenza epidemic season in Ukraine in late 2000 and early 2001. Infectious Diseases, 2002, no. 2, pp. 95-99.

274. Frolov, A.F. THE CONCEPT OF infection eradication at the present stage. Modern Infections, 2002, no. 1, pp. 4-10.

275. Frolov, A.F., & Frolov, V.M. (2004). Effectiveness of the combination of amizon and glutargin in emergency chemoprophylaxis of influenza during an epidemic threat period. In Viral Diseases. Toxoplasmosis. Chlamydiosis: Proceedings of the Scientific and Practical Conference and Plenary Session of the Association of Infectiologists of Ukraine (May 5-6, 2004, Ternopil) (pp. 219-221). Ternopil: Ukrmedkniga.

276. Khaitov, R.I., & Pinegin, B.V. (2000). Current Concepts of body defense against infection. Immunologiya, (1), 61-64.

277. Khaitov, R.I., & Pinegin, B.V. (2000). Modern immunomodulators: Basic principles of their application. Immunologiya, (5), 4-7.

278. Khaitov, R.I., Nekrasov, A.V., & Puchkova, N.G. (2003). Epidemiological and economic efficiency of immunization with Grippol vaccine for influenza and acute respiratory viral infections in adults. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii, (3), 83-86.

279. Kharchenko, Yu.P., Mykhailova, A.M., Yurchenko, I.V., & Kostenko, S.O. (2004). The use of tonsilogen in the complex therapy of acute respiratory viral infections. In Viral Diseases. Toxoplasmosis. Chlamydiosis: Proceedings of the Scientific and Practical Conference and Plenary Session of the Association of Infectiologists of Ukraine (May 5-6, 2004, Ternopil) (pp. 223-225). Ternopil: Ukrmedkniga.

280. Khlyustov, S.V., Rytik, P.G., & Kucherov, I.I. (1986). Respiratory syncytial viral infection. Zdravookhranenie Belorussii, (6), 42-44.

281. Khodak, L.A. (2002). Acute respiratory diseases: An inexhaustible problem of medicine. International Medical Journal, 8(1-2), 188-191.

282. Khurgin, Yu.I. (1995). Interaction of EHF radiation with the aqueous component of metabolite solutions and biological fluids. In Millimeter Waves in Biology and Medicine: Proceedings of the 10th Russian Symposium with International Participation (pp. 211-212).

283. Chebotareva, T.A., Timina, T.P., Malinovskaya, V.V., & Pavlova, L.A. (2000). The use of viferon in influenza and other acute respiratory viral infections in children. Detskiy Doktor, (5), 16-18.

284. Chemych, M.D., & Ilyina, N.I. (2001). Clinical features of acute respiratory viral infections under modern conditions. In Neuroinfections and Other Infectious Diseases: Proceedings of the Scientific and Practical Conference and Plenary Session of the Association of Infectiologists of Ukraine (April 26-27, 2001, Kharkiv) (pp. 271-273). Ternopil: Ukrmedkniga.

285. Chemych, M.D., & Ilyina, N.I. (2004). Features of the clinical picture and course of viral diseases affecting the upper respiratory tract. In Viral Diseases. Toxoplasmosis. Chlamydiosis: Proceedings of the Scientific and Practical Conference and Plenary Session of the Association of Infectiologists of Ukraine (May 5-6, 2004, Ternopil) (pp. 234-236). Ternopil: Ukrmedkniga.

286. Chemych, M.D. (2004). Integrative indices of endogenous intoxication and their sex and age dependence. In Viral Diseases. Toxoplasmosis. Chlamydiosis: Proceedings of the Scientific and Practical Conference and Plenary Session of the Association of Infectiologists of Ukraine (May 5-6, 2004, Ternopil) (pp. 371-373). Ternopil: Ukrmedkniga.

287. Chirkova, T.V., Naykhin, A.N., Donina, S.A., et al. (2006). Production of serum and local IgE in young people during influenza infection and immunization with live influenza vaccine. Allergologiya, (1), 33-37.

288. Chornovil, A.V., Hrytsko, R.Yu., & Birka, H.Yu. (2001). The use of antioxidant Vitamins in infectiology. Infectious Diseases, (2), 55-58.

289. Shabalina, N.V., Dlin, V.V., Malinovskaya, V.V., et al. (1995). The human interferon system: Biological role and relationship with the immune system. Russian Bulletin of Perinatology and Pediatrics, (5), 29-35.

290. Shatalin, K.Yu., & Zvonarev, A.Yu. (1995). Biotechnology in the development of methods and tools for diagnosing viral infections. Problems of Virology, (3), 98-100.

291. Shakhanina, K.L. (1998). Influenza and acute respiratory diseases as a priority socio-economic healthcare problem. Zdravookhranenie, (9), 169.

292. Shestakova, I.V., Duda, O.K., & Gubenko, I.M. (2002). Errors in influenza diagnosis at the pre-hospital stage. In Clinical Problems of Combating Infectious Diseases: Proceedings of the 6th Congress of Infectiologists of Ukraine (September 25-27, 2002, Odesa) (pp. 447-448). Ternopil: Ukrmedkniga.

293. Shumilov, V.I., Shuster, A.M., Lobastov, S.P., et al. (2002). Efficacy of arbidol in the prevention and treatment of acute respiratory infections in military personnel. In Clinical Problems of Combating Infectious Diseases: Proceedings of the 6th Congress of Infectiologists of Ukraine (September 25-27, 2002, Odesa) (pp. 54-59). Ternopil: Ukrmedkniga.

294. Shuster, A.M., Shumilov, V.I., Shevtsov, V.V., et al. (2004). Prevention of acute respiratory VIRAL INFECTIONS AND their complications with arbidol in military personnel. Military Medical Journal, 325(9), 44-45.

295. Tselipanova, E.E., Shebekova, V.M., Feklisova, L.V., et al. (2003). Microbiocenosis of the upper respiratory tract mucous membranes and its correction using acipol in the treatment of patients with ARVI. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii, (2), 65-67.

296. Tsybalova, L.M., Osidak, L.V., & Popova, T.L. (2003). Incidence of influenza and other acute respiratory diseases in the population of areas contaminated with low doses of radionuclides. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii, (6), 60-63.

297. Shchegoleva, L.S., Zhilina, L.P., Fardzinova, V.F., & Dobrodeeva, L.K. (2004). Immune response of vaccinated Northern women (residents of Arkhangelsk) immunized with Grippol. Clinical Laboratory Diagnostics, (3), 43-46.

298. Shcherbinska, A.M., & Rudenko, A.O. (1997). Prevention of influenza and other acute respiratory diseases. Journal of the Practical Physician, (1), 4-5.

299. Yuzhanina, V.N. (2001). Interferon production in experimental influenza infection. In Neuroinfections and Other Infectious Diseases: Proceedings of the Scientific and Practical Conference and Plenary Session of the Association of Infectiologists of Ukraine (April 26-27, 2001, Kharkiv) (pp. 280-281). Ternopil: Ukrmedkniga.

300. Yupatov G.I., Dotsenko E.A., Chirkin A.A. Interrelation of Cholesterol level, Lipoproteins, and immunity to acute respiratory viral infections // Immunopathology. Allergology. Infectology. - 2003. - № 2. - P. 28-35.

301. Yakovenko L.F., Romashchenko O.V., Spivak M.Y. et al. Interferon preparations in the complex therapy of infectious diseases of bacterial etiology // Liky. - 2001. - № 1-2. - P. 59-70.

302. Yarilin A.A. Cytokines in the Thymus. Production and response of cytokines // Cytokines and Inflammation. - 2003. - V. 2, № 1. - P. 3-13.

303. Yashin A.A. The phenomenon of stochastic Resonance in biosystems under the influence of an external electromagnetic field and its role in the regulation of Free energy // Physics of the Alive. - 2000. - V. 8, N 2. - P. 14-28.

304. Adolf G.R. Human interferon omega-a review // Mult. Scler. - 1995.- V. 1, Suppl. 1. - S. 44-47.

305. Alexenko A.P., Leaman D.W., Roberts R.M. The antiproliferative and antiviral activities of IFN-tau variants in human cells // J. Interferon Cytokine Res. - 1997. - V. 17. - P. 769-779.

306. Anderson E.Z., Newman F.K., Maassab H.F., Belshe R.B. Evalution of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children // J. Clin. Microbiol. - 1992. - V. 30. - P. 2230-2234.

307. Azzi A., Bartolomei-Corsi O., Zakrewska K. et al. The haemagglutinins of influenza A(H1N1) viruses in the «O» or «D» phases exhibit biological and antigenic differences // Epidemic. Infect. - 1993. - V. 111. - P. 135-142.

308. Banchereau J., Steinman R-M. Dendritic cells and the control of immunity // Nature. - 1998. - V. 392. - P. 245-252.

309. Barnes B., Lubyova B., Pitha P. On the role of IRF in host defense // Interferon Cytokine Res. - 2002. - V. 22. - P. 59-71.

310. Basinga M. Viruses launch their own star wars // Science. - 1992. - V. 258. - P. 1730-1731.

311. Bennett E.M., Bennink J.R., Yewdell J.W. et al. Cutting edge: Adenovirus E19 has two mechanisms for affecting Class 1 MHC expression // J. Immunol. - 1999. - V. 162, № 9. - Р. 5049-5052.

312. Belche R.B., Mendelman R.M., Treanor J. et al. The efficacy of live alternated, cold-adaptated, trivalent, intranasal influenza virus vaccine in children // New Engl. J. Med. - 1998. - V. 338. - P. 1405-1412.

313. Burnett E.D. Influenza immunization for children // New Engl. J. Med. - 1998. - V. 338. - P. 1459-1461.

314. Demmler G.J. Diagnosing influenza: Just how accurate are the new rapid tests? // J. Respiratory Dis. - 2000. - V. 21, № 11. - P. 661-665.

315. Ito T., Amakawa R., Inaba M. et al. Differential Regulation of human blood dendritic cell subsets by IFNy // J. Immunol. - 2001. - V. 166. - P. 2961-2969.

316. Eichwald C., Kaiser F., Walleczek J. Non-linear dynamics and biophysical systems, Theoretical modeling of intracdiulaf calcium-signaling pathways under the Influence of External electromagnetic fields // Kleinheubacher Bcrichte. - 1994. - V. 37. - P. 771-778.

317. Eichwald C., Kaiser F. Model for external influences on cellular signal Transduction pathways including cytosolic calcium oscillations // Bioelectromagnetics. - 1995. - V. 16. - P. 75-85.

318. Clements M.L., Belts R.F., Tierney E.L., Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-tipe virus // J. Clin. Microbiol. - 1986. - V. 24. - P. 157-160.

319. Cox N.J., Fukuda K.A. Influenza // Infect. Dis. Clin. N. Amer. - 1998. - V. 12. - P. 27-37.

320. Cretescu L., Beare A., Schild G. Formation of antibody to matrix protein in experimental human influenza A virus infection // Infect. Immun. - 1998. - V. 22. - P. 322-327.

321. Day R.O., Grahat G.G., Whelton A.O. THE POSITION OF paracetamol in the word of analgesis // Amer. J. Ther. - 2000. - V. 7, № 2. - P. 51-54.

322. Demmler G.J. Diagnosing influenza: Just how accurate are the new rapid tests? // J. Respiratory Dis. - 2000. - V. 21. - P. 661-665.

323. Garcia-Sastre A., Durbin R., Zheng H. et al The role of interferon in influenza virus tissue tropism // J. Virol. - 1998. - V. 72. - P. 8550-8558.

324. Generation and evaluetion of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate / H. Chen, K. Subbarao, D. Swayne et al. // Vaccine. - № 21. - P. 1974-1979.

325. Goading L.R. Virus Proteins that counteract host immune defenses // Cell. - 1992. - V. 71. - P. 5-7.

326. Goings S.A.J., Kulle T.J., Bascom R.S.Z. et al. Effect of nitrogen dioxide exposure on susceptibility to influenza A virus infection in healthy adults // Amer. Rev. Resp. Dis. - 1989. - V. 139. - P. 1073-1081.

327. Gorban E.N., Tronko N.D., Pasteur I.P. el al. The influenza of electromagnetic ultrahigh-frequency radiation on absorption of iodine by the organic culture of Thyroid Gland // Physics of the Alive. - 1996. - V. 4, № 1. - P. 133-136.

328. Guun Y., Shortrige K., Krauss S. et al. Emergence of avian H1N1 Influenza Viruses in pigs in China // J. Virol. - 1996. - V. 70. - P. 8041­8046.

329. Guan Y., Shortrige K.F., Krauss S., Webster R.G. Molecular characterization of H9N2 influenza viruses: were they the Donors of the «internal» genes of H5N1 viruses in Hong Kong? // Prok. Nate. Asad. Sci. USA. - 1999. - V. 96. - P. 9363-9367.

330. Guo Y., Wang M., Kavaoka Y. et al Characterization of new avian like influenza A virus from horses in China // Virology. - 1992. - V. 188. - P. 245-255.

331. Influenza / Eds J. Suss, L. Dohner et al. - Jena, 1987.

332. Hartshorn K., Sastry K., Brown D. et al. Conglutinin Acts as an Opsonin for Influenza A viruses // J. Immunol. - 1993. - V. 151. - P. 6265­6273.

333. Hsia J., Tang T., Paroff M. et al. Augmentation of the immune respronse to influenza vaccine // Meth. Find. Exp. Pharmacol. - 1994. - V. 16. - P. 677-683.

334. Lorio A.M., Zei T., Neri M., Alalri A. Possible correlation between low antigenic drift of A (H1N1) influenza viruses and induction of HI antibodies // Gen. J. Epidemic. - 1997. - V. 12. - P. 589-594.

335. Jakeman K., Smith H., Sweet C. Mechanism of immunity to influenza: material and passive neonatal protection following immunisation of adault ferrets with a live vaccina-influenza virus recombinants containing other influenza virus proteins // J. Gen. Virol. - 1989. - V. 70. - P. 1523­1531.

336. Johansson B., Ditcher D., Kilbourne E. Puriafied influenza virus haemagglutinin and neiraminidase are equivalent in stimulation on antibody response but induced contrasting Types of Immunity to infection // J. Virol. - 1989. - V. 93, N 63. - P. 1239-1246.

337. Jong J.S., Claus E.C., Osterhaus A.D. Influenza A(H5N1) in Hong Kong: Forerunner of pandemic or just a scientifically interesting phenomenon and useful exercise in pandemiology? // Ned. lijdshr. Geneeskd. - 1998. - V. 142. - P. 1252-1256.

338. Kaiser L., Couch R.B., Galasso G.J. et al. First international symposium on influenza and other respiratory viruses: summary and Overview: Kapalua, Maui, Hawaii, December 4-6, 1998 // Antiviral Res. - 1999. - V. 42. - P. 149-175.

339. Katz J.M., Wang M.I., Webster R.G. Direct sequencing of the HA Gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus // J. Virol. - 1990. - V. 64. - P. 1808-1811.

340. Kibourne E. Influenza Pandemic of the Century // Emerging Inf. Dis. - 2006. - V. 12, № 1. - P. 9-14.

341. Kierszenbaum R., Sonnenfeld G. Characterization of the antiviral activity produced during Trypanosoma cruzi infection and protective effects of exogenous interferon against experimental Chagas disease // J. Parasitol. - 1982. - V. 68. - P. 194-198.

342. Kenclal A.P. Cold-adapted live attenuated influenza vaccines developed in Russia: canthey conribute to meeting the needs influenza control in other countries // Europ. J. Epidemiol. - 1997. - V. 13. - P. 591­609.

343. King J.C., Zagos R.O., Bernstein B.J. et al Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administrated intranasally a drops or spray to healty children // J. Infect. Dis. - 1998. - V. 177. - P. 1394-1397.

344. Kinnunen L., Ikonen N., Pory T., Pyhala R. Evolution of influenza B/Victoria/2/87-like viruses: occurrence of a genetically conserved virus under condition of low epidemic activity // J. Gen. Virol. - 1992. - V. 73. - P. 733-736.

345. Lamaire V. Fantil vacciner tons les adultes contra la grippe? // Concours med. - 1996. - V. 118. - P. 8-10.

346. Levy D.E. Whence Interferon? Variety in The production of Interferon in Response to Viral Infection // J. Exp. Med. - 2002. - V. 195. - Р. 15-18.

347. Luft T., Pang K., Thomas E. et al. Type I IFNs enhance the terminal differentiation of dendritic cells // J. Immunol. - 1998. - V. 161. - P. 1947­1953.

348. Landon L.M., Walter E.B., Bland C.L., Clements D.A. The ability of influenza A vaccine to reduze the incidence of acute outis in 6 to 30 month old day cace children // Clin. Infect. Dis. - 1994. - V. 19. - P. 600.

349. Lindstrom S., Sugita S., Endo A. et al. Evolutionary characterization of recent human H3N2 influenza A isolates from Japan and China: novel Changes in the receptor binding domain // Arch. Virol. - 1996. - V. 141. - P. 1349-1355.

350. Li Fang Qin-Yuan, Zhu Bao-Zi, Wang Min. Antiviral effects of rh IFN-alfa 1 against seven influenza Viruses // Sin. - 1999. - V. 20. - P. 709­714.

351. Ludwig S., Stilz L, Planz O. et al. European swine virus as a possible source for the next influenza pandemic? // Virology. - 1995. - V. 212. - P. 555-561.

352. Lupulescu E., Lonita E., Cuceanu N. et al. Characterization of the local and sistemic immune response by the inactived influenze vaccine administred orally or parenterally // Rom. Arch. Microbiol. Immunol. - 1994. - V. 53. - P. 273-284.

353. Meddlers J.A., Wang G.C., He S., Webster R.G. Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature // J. Virol. - 1999. - V. 73. - P. 7343-7348.

354. McElbancy J.E., Mencilly G.S., Lechell K.E. et al. Antibiody respronse to whole-virus and split-virus influenza vaccines in successful again // Clin. Infect. Med. - 1993. - V. 16. N 4. - P. 56.

355. Monto A.S., Robinson D.P., Herlocher M.L. et al. Zanamavir in the prevention of influenza among healthy adults: a randomised controlled trial // JAMA. - 1999. - V. 282. - P. 31-35.

356. Morishita N., Nobusawa E., Nakajima K., Nakajima S. Studies on the molecular basis for loss of theability of recent influenza A (H1N1) virus strains to agglutinate chicken erythrocytes // J. Gen. Virol. - 1996. - V. 77. - P. 2499-2506.

357. Nerome R., Hiromoto Y., Sugita S. et al. Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic Circulation of deletion and insertion mechanism // Arch. Virol. - 1998. - V. 143. - P. 1569-1583.

358. Pestka S.O., Langer J.A., Zoon K.C., Samuel C.E. Interferons and their actions // Annu Rev. Biochem. - 1987. - V. 56. - P. 727-777.

359. Prevention and control of influenza: recommendations of Advisory Committee on Immunization Practices (ACIP) // MMWR Morb Motral Wkly Rep. - 2000. - V. 49. - P. 1-38.

360. Preparing for this year's influenza season // J. Respiratory Dis. - 2000. - V. 21. - P. 551-557.

361. Pyhll R., Ikonen N., Forsten T. et al. Evolution of the HA1 domain of human influenza A(H1N1) virus: loss of glycosylation sites and occurrence of herald and conserved strains // J. Gen. Virol. - 1995. - V. 76. - P. 205­210.

362. Randomised trial of eficacy and safety of inhaled zanamivir in treatment of influenza A and В virus infections. The MIST (Management of influenza in the Southern Hemisphere Trialists) Study Group // Lancet. - 1998. - V. 352. - P. 1877-1881.

363. Reemerging H5N1 influenza viruses in Hong Kong in 2002 are higly pathogenic to ducks / K. Sturm-Ramires, T. Ellis, B. Bousfield et al. // J. Virol. - 2004. - № 78. - P. 4892-4901.

364. Robertson J., Nicolson C., Boatman J. et al. Sequence Analysis of the haemagglutinin (HA) of influenza A(H1N1) viruses present in clinical material and comparison with the HA of laboratory derived virus // J. Gen. Virol. - 1991. - V. 72. - P. 2671-2677.

365. Ryan-Poirier K., Suzuki Y., Bean W. et al. Changes in H3 influenza A virus receptor specificity during Replication in humans // Virus. Res. - 1998. - V. 56. - P. 169-176.

366. Seder R.A., Hill A.V. Vaccines againts intracellular infections reguiring celluar immunity // Nature (Gr. Brit). - 2000. - V. 406. - Р. 793­801.

367. Sareneva T., Matikainen S., Kurimoto M., Julkunen I. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma Gene Expression IN human T cells // J. Immunol. - 1998. - V. 10. - P. 6032­6038.

368. Stordeur P., Poulin L., Cracium L. et al. Cytokyne mRNA quantification by real-time PCR // J. Immunol. Meth. - 2002. - V. 259, 1. - P. 55-64.

369. Sotomayor E., Borrello L., Tubb E. et al. Conversion of tumor- specific CD4+ T-cell tolerance to T-cell priming through in vivo li-gation of CD40 // Nat. Med. - 1999. - V. 5. - P. 780-787.

370. Sheppard P., Kindsvogel W., Xu W. et al. L-28, IL-29 and their class II cytokine receptor IL-28R // Nat. Immunol. - 2003. - V. 4. - P. 63-68.

371. Zinkernagel R., Hengartner H. Antiviral immunity // Immunol. Today. - 1997. - V. 18. - Р. 287.

372. Scharfenorth H., Glathe H., Giese H., Diffmann S. Zur Epidemiologie und Klinik der Influenza C-Infektion // Z. Klin. Med. - 1991. - V.46. - Р. 1183-1187.

373. Scholtissek C. Molecular evolution of influenza viruses // Virus. Genes. - 1996. - V. 11. - P. 209-215.

374. Steinhoff M.C., Halsey N.A., Wilson N.H. et al. Comparison of live attenuated cold adapted and avian-human influenza A (Bethesda/85 (H3N2)) reassortant virus vaccines in infants and children // J. Infect. Diseases. - 1990. - V. 112. - P. 394-401.

375. Suarez D.L., Perdue M.L., Cox N.J. et al. Comparisons of highly virulent H5N1 influenza A virus isolated from humans and chickens from Hong Kong // J. Gen. Virol. - 1998. - V. 72. - P. 6678-6688.

376. Subbarao K., Klimov A., Katz J. et al. Characterization of an avian influenza A(H5N1) virus isolated from a child with a fatal respiratory illness // Science. - 1998. - V. 279. - P. 393-396.

377. Takauji R., Iho S., Takatsuka H. et al. CpG-DNA-induced IFN-a production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors // J. Leukoc. Biology. - 2002. - V. 72. - P. 1011-1019.

378. Takei K., McPherson P., Schmid S., De Camilli P. Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals // Nature. - 1995. - V. 374. - P. 186-190.

379. Tamura S., Funato H., Hirabayashi V. et al. Functional role of respiratory tract haemagglutinin-specific Ig antibodies in protection against influenza // Vaccine. - 1990. - N 8. - P. 479-485.

380. Tan W., Xiang X., Qiu D. et al. Epidemiology of respiratory viruses in patients hospitalized with nearfatal asthma, acute exacerbations of asthma or chronic obstructive pulmonary disease // Am. J. Med. - 2003. - V. 115. - P. 272-277.

381. Tebo J.M., Kim H.S., Gao J. Interleukin-10 suppresses IP-10 gene Transcription by inhibiting the production of class I interferon // Blood. - 1998. - V. 92. - P. 4742-4749.

382. Tough D., Borrow P., Sprent J. Induction of bystander T-cell proliferation by viruses and type I interferon in vivo // Science. - 1996. - V. 272. - P. 1047-1050.

383. Treanor J.J. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized, controlled trial // JAMA. - 2000. - V. 283. - 1016-1024.

384. Fantuzzi L., Puddu P., Varano B. et al. IFN-alpha and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12- induced IFN-gamma production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages // J. Leukoc. Biol. - 2000. - V. 68. - P. 707-714.

385. Fehniger T.A., Caligiuri M.A. Interleukin-15: biology and relevance to human disease // Blood. - 2001. - V. 97. - P. 14-32.

386. Fedson D.S. Pandemic influenza and the global vaccine supply // Clin. Infect. Dis. - 2003. - V. 36. - Р. 1552 -1561.

387. Velichko S., Wagner C., Turkson J. et al. Activation by Type I Interferons is Dependent on Specific Tyrosines Located in the Cytoplasmic Domain of Interferon Receptor Chain 2 c // J. Biol. Chem. - 2002. - V. 277. - P. 635-641.

388. Vilcek J. Novel interferons // Nature Immunology. - 2003. - Vol. 4. - P. 8-9.

389. Wenner C.A., Guler M.L., Macatonia S.E. et al. Roles of IFN-gamma and IFN-alfa in IL-12-induced T helper cell-1 development // J. Immunol. - 1996. - V. 156. - P. 1442-1447.

390. Webster R.G., Hinshaw V.S., Bean W.J. et al. Characterization of influenza A virus from seals // Virology. - 1981. - V. 113. - P. 712-724.

391. Webster R.G., Hulse D.J. Microbial adaptation and change: avian influenza // Rev. Sci. Tech. - 2000. - V. 23, № 2. - P. 453-465.

392. Welliver R.W. et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial // JAMA. - 2001. - V. 285. - Р. 748-754.

393. Whitely R.J., Hayden F.G. et al. Oral oseltamivir treatment of influenza in children // Pediatr. Infect. Dis. J. - 2000. - V. 20. - Р. 122-133.

394. Whitley R.J., Hayden F.G., Reisinger K.S. Oral oseltamivir treatment in children // Pediatr. Infect. Dis. J. - 2001. - № 2. - P. 127-133.

395. Wraith D. The recognition of influenza A virus-infected cells by cytotoxic T-lymphocytes // Immunol. Today. - 1987. - V. 8. - P. 239-246.

396. Welliver R.C. Respiratory syncytial virus and other respiratory viruses // Pediatr. Infect. Dis. J. - 2003. - V. 22. - P. 6-12.

397. Yeow W.S., Lawson C.M., Beilharz M.W. Antiviral activities of individual murine IFN-OC subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication // J. Immunol. - 1998. - V. 160. - P. 2932-2939.